Rheolytic thrombectomy (angiojet) in the treatment of acute thrombosis

  • Interventional procedures
  • Not in remit

Details

Date notified to NICE:
29 April 2005
Topic area:
Reason:
Concerns relate to pharmaceutical agent
Explanation:

Concerns relate to pharmaceutical agent - The risks and benefits of the procedure are sufficiently well known and the concerns over the safety and efficacy of the procedure are related solely to the use of a pharmacological agent/ medical device rather than to the procedure itself.

To fall within the Programme's remit, a notified procedure must involve an incision or a puncture or entry into a body cavity, or the use of ionising, electromagnetic or acoustic energy.

This page was last updated: 30 March 2010

Patient

The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.

Quick Reference Guide

The quick reference guide presents recommendations for health professionals

NICE Guidance

The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.

Full Guidance

The published full clinical guidance for specialists with background, evidence, recommendations and methods used.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.